A bad-tempered exchange at a medical-cannabis conference has highlighted a strong disagreement between the Canadian Medical Association (CMA) and some of its members on how medical cannabis should be regulated when the drug becomes legal. Dr. Jeff Blackmer, CMA’s vice-president of medical